Month: May 2020

RAPID CITY, S.D., May 13, 2020 (GLOBE NEWSWIRE) — Black Hills Corp. (NYSE: BKH) today announced that members of its senior management team will visit with investors May 14 during the Credit Suisse 2020 Utilities, Power & Clean Tech Virtual Conference and May 18 and 19 during the virtually hosted American Gas Association Financial Forum.Management reaffirms its guidance range most recently issued on May 5, and will be available to discuss guidance, its response to the COVID-19 pandemic and related impacts on the company’s business.The materials produced for these meetings will be available on the Black Hills Corp. website at www.blackhillscorp.com under the “Investor Relations” section prior to the meetings.Black Hills CorporationBlack Hills Corp. (NYSE: BKH) is a customer-focused, growth-oriented utility company with a tradition...

BURLINGAME, Calif., May 13, 2020 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted oncology therapies and the utilization of novel biomarkers to enhance patient selection, today announced that updated data reporting refinements of the Adenosine Gene Signature  as a predictive biomarker for patients treated with ciforadenant, the Company’s adenosine A2A receptor antagonist, will be presented in an electronic poster presentation at the American Society of Clinical Oncology’s (ASCO) upcoming ASCO20 Virtual Scientific Program, to be held May 29-31, 2020.The data is based on results from  the Company’s Phase 1b/2 clinical trial of ciforadenant in patients with advanced refractory renal cell cancer (RCC) and...

Not for distribution to U.S. News wire services or dissemination in the U.S.VANCOUVER, British Columbia, May 13, 2020 (GLOBE NEWSWIRE) — The Keg Royalties Income Fund (the “Fund”) (TSX: KEG.UN) and Keg Restaurants Ltd (“KRL”) are pleased to announce the financial results of the Fund for the first quarter of 2020.HIGHLIGHTSAll 106 Keg restaurants in the Royalty Pool closed as at March 17, 2020 due to the COVID-19 pandemicKRL system sales down 14.3% to $144.1M for the 13-week periodKRL same store sales down 0.3% for the comparable 8-week periodsRoyalty Pool sales down 13.9% to $142.7M for the quarterDistributable cash up 7.4% to 36.6 cents/Fund unit for the quarterPayout ratio was 77.6% for the first quarter of 2020The Royalty Pool sales reported by the 106 Keg restaurants in the Royalty Pool were $142,653,000 for the quarter, a decrease...

MALVERN, Pa., May 13, 2020 (GLOBE NEWSWIRE) — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today announced a retrospective analysis of Phase 2b trial data demonstrating the potential renal protective activity of lead candidate avasopasem manganese (GC4419), and two ongoing clinical trials evaluating avasopasem, will be presented at the American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program, taking place May 29-31, 2020. Abstracts are available now in the ASCO digital program, and presentations will be available for on-demand viewing on May 29, 2020, at 8 a.m. EDT.“We look forward to sharing important clinical updates that...

Delray Beach, FL, May 13, 2020 (GLOBE NEWSWIRE) — Forum Merger II Corporation (Nasdaq: FMCI) (“Forum” or the “Company”) today announced it has signed a letter of intent and expects to sign a definitive agreement to acquire a high-growth, plant-based food company with a broad portfolio of innovative products that are aligned with major food trends and sold through leading retailers and distributors across the United States (the “Target”).The Target’s disruptive strategy is focused on addressing the growing consumer demand for nutritious, great tasting, better-for-you products with plant-based food. The Target’s alignment with today’s secular food trends, combined with its robust, plant-based offerings that feature unique ingredients, innovative recipes and creative branding, has allowed it to establish a meaningful market presence...

SOUTH SAN FRANCISCO, Calif., May 13, 2020 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on its Probody® therapeutic technology platform, today announced further details of oral and poster presentations at the American Society of Clinical Oncology’s (ASCO) ASCO20 Virtual Scientific Program taking place from May 29 – May 31, 2020.Presentation titles, presenters and timing are listed below with all abstracts available at the ASCO20 Meeting Library.CytomX’s ASCO20 clinical presentations for CX-072 (Abstract 3005), CX-2009 (Abstract 526) as well as CX-2029 (Abstract 3502), developed in partnership with AbbVie, will have data cutoff dates of approximately five months later than the abstract...

GAITHERSBURG, Md., May 13, 2020 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced financial results for the quarter ended March 31, 2020 and provided a business update.“Throughout 2020 we have put significant effort into developing our pipeline; from advancing our vaccine candidates, AdCOVID and Nasoshield, to IND enabling studies and manufacturing for ALT-801 and HepTcell,” said Vipin K. Garg, Ph.D., President and Chief Executive Officer. “Based on our progress, we are poised for a data-rich year, with the expected initiation of NasoShield, ALT-801 and AdCOVID clinical trials.”Recent HighlightsPreclinical testing commences on COVID-19 vaccine candidate, AdCOVIDIn collaboration with the University of Alabama at Birmingham (UAB), we have commenced preclinical testing of...

TORONTO, May 13, 2020 (GLOBE NEWSWIRE) — Martinrea International Inc. (TSX : MRE), a diversified and global automotive supplier engaged in the design, development and manufacturing of highly engineered, value-added Lightweight Structures and Propulsion Systems, today announced the release of its financial results for the first quarter ended March 31, 2020.HIGHLIGHTSTotal sales of $872.7 million; production sales of $822.5 millionFirst quarter diluted net earnings per share of $0.36First quarter diluted adjusted net earnings per share(1) of $0.38Unfavourable impact of shutdowns related to COVID-19 in the quarterQuarterly free cash flow(1) of $9.9 millionBalance sheet ended the quarter strong; net debt(1):adjusted EBITDA(1) ratio (excluding impact of IFRS 16) of 1.62xCompany has taken aggressive cash conservation measuresCompany has...

CAMBRIDGE, Mass. and NEW YORK, May 13, 2020 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic therapies, today announced that the design of MasterKey-01, the Company’s first-in-human Phase 1/2 clinical trial for its lead product candidate BDTX-189, will be presented as a poster presentation at the American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program, taking place from May 29-31, 2020. The abstract, published in advance of the ASCO Annual Meeting, was made available at 5:00 PM ET today on the ASCO meeting website at https://meetinglibrary.asco.org/record/191686/abstract.Details of the abstract presentation are as follows:Abstract TPS3665Hamilton et al. Masterkey-01: Phase I/II,...

ACTON, Mass., May 13, 2020 (GLOBE NEWSWIRE) — Psychemedics Corporation (NASDAQ:PMD) today announced first quarter financial results for the period ended March 31, 2020. The Company’s revenue for the quarter ended March 31, 2020 was $7.5 million versus $9.8 million for the quarter ended March 31, 2019, a decrease of 23%.  Net loss for the quarter ended March 31, 2020 was $0.2 million or ($0.03) per diluted share, versus net income of $0.6 million or $0.11 per diluted share, for the comparable period last year, a decrease of $0.14 per diluted share.Raymond C. Kubacki, Chairman and Chief Executive Officer, stated:“As with many companies, first quarter revenues and earnings were negatively impacted by the coronavirus pandemic (“COVID-19”).   “While the impact from COVID-19 affected the Company’s sales volumes, it did not impact...